Comments
Loading...
Foghorn Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:FHTX | Benzinga
Foghorn Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 14
EPS
$-0.300
Quarterly Revenue
$5.95M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$22.60M
Analyze the earnings history of Foghorn Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| FHTX | Foghorn Therapeutics | -$0.45 | — | — | — | $6.89M | — | — | — | 08/07/2025 | Get Alert |
| FHTX | Foghorn Therapeutics | -$0.59 | -$0.24 | -$0.30 | -25.00% | $5.05M | $5.45M | $5.95M | 9.21% | 05/14/2025 | Get Alert |
| FHTX | Foghorn Therapeutics | -$0.57 | -$0.27 | -$0.23 | 14.81% | $5.77M | $8.14M | $2.86M | -64.91% | 03/06/2025 | Get Alert |
| FHTX | Foghorn Therapeutics | -$0.34 | -$0.44 | -$0.31 | 29.55% | $17.48M | $6.34M | $7.81M | 23.15% | 11/04/2024 | Get Alert |
| FHTX | Foghorn Therapeutics | -$0.70 | -$0.65 | -$0.45 | 30.77% | $5.60M | $6.04M | $6.89M | 14.04% | 08/08/2024 | Get Alert |
| FHTX | Foghorn Therapeutics | -$0.73 | -$0.63 | -$0.59 | 6.35% | $5.31M | $6.91M | $5.05M | -26.92% | 05/06/2024 | Get Alert |
| FHTX | Foghorn Therapeutics | -$0.69 | -$0.76 | -$0.57 | 25.00% | $4.18M | $4.62M | $5.77M | 24.87% | 03/07/2024 | Get Alert |
| FHTX | Foghorn Therapeutics | -$0.62 | -$0.75 | -$0.34 | 54.67% | $6.63M | $4.52M | $17.48M | 286.68% | 11/02/2023 | Get Alert |
| FHTX | Foghorn Therapeutics | -$0.66 | -$0.73 | -$0.70 | 4.11% | $4.49M | $6.26M | $5.60M | -10.56% | 08/04/2023 | Get Alert |
| FHTX | Foghorn Therapeutics | -$0.65 | -$0.72 | -$0.73 | -1.39% | $3.92M | $5.04M | $5.31M | 5.34% | 05/08/2023 | Get Alert |
| FHTX | Foghorn Therapeutics | -$0.77 | -$0.62 | -$0.69 | -11.29% | $713.00K | $8.48M | $4.18M | -50.66% | 03/09/2023 | Get Alert |
| FHTX | Foghorn Therapeutics | -$0.71 | -$0.62 | -$0.62 | 0.00% | $41.00K | $9.20M | $6.63M | -27.89% | 11/08/2022 | Get Alert |
| FHTX | Foghorn Therapeutics | -$0.63 | -$0.59 | -$0.66 | -11.86% | $279.00K | $8.69M | $4.49M | -48.33% | 08/09/2022 | Get Alert |
| FHTX | Foghorn Therapeutics | -$0.62 | — | -$0.65 | — | $286.00K | — | $3.92M | — | 05/09/2022 | Get Alert |
| FHTX | Foghorn Therapeutics | $2.53 | -$0.74 | -$0.77 | -4.05% | $251.00K | $330.00K | $713.00K | 116.06% | 03/10/2022 | Get Alert |
| FHTX | Foghorn Therapeutics | -$3.12 | — | -$0.71 | — | $179.00K | — | $41.00K | — | 11/09/2021 | Get Alert |
| FHTX | Foghorn Therapeutics | — | — | -$0.63 | — | — | — | $279.00K | — | 08/10/2021 | Get Alert |
| FHTX | Foghorn Therapeutics | — | — | -$0.62 | — | — | — | $286.00K | — | 05/11/2021 | Get Alert |
| FHTX | Foghorn Therapeutics | — | — | $2.53 | — | — | — | $251.00K | — | 03/18/2021 | Get Alert |
| FHTX | Foghorn Therapeutics | — | — | -$3.12 | — | — | — | $179.00K | — | 12/04/2020 | Get Alert |
Foghorn Therapeutics (FHTX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q1 | 2025-05-14 | $-0.30 | $-0.24 | -25.0 % |
| Q4 | 2025-03-06 | $-0.23 | $-0.27 | 14.8 % |
| Q3 | 2024-11-04 | $-0.31 | $-0.44 | 29.5 % |
| Q2 | 2024-08-08 | $-0.45 | $-0.65 | 30.8 % |
Foghorn Therapeutics (FHTX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q1 | 2025-05-14 | $5.95M | $5.45M | 9.21 % |
| Q4 | 2025-03-06 | $2.86M | $8.14M | -64.9 % |
| Q3 | 2024-11-04 | $7.81M | $6.34M | 23.2 % |
| Q2 | 2024-08-08 | $6.89M | $6.04M | 14.0 % |
FAQ
When is Foghorn Therapeutics (NASDAQ:FHTX) reporting earnings?
Foghorn Therapeutics (FHTX) is scheduled to report earnings on August 7, 2025. The last reported earnings were for reported on May 14, 2025 for Q1.
What were the latest earnings per share (EPS) for Foghorn Therapeutics (NASDAQ:FHTX)?
The Actual EPS was $-0.30, which missed the estimate of $-0.24.
What were Foghorn Therapeutics’s (NASDAQ:FHTX) revenues?
The Actual Revenue was $6M, which beat the estimate of $5.5M.
Browse earnings estimates, EPS, and revenue on all stocks.
